Infectious Diseases Division


About the Division

The Infectious Diseases (ID) Division, Department of Medicine, spans the globe with approximately 165 faculty appointments. Many faculty are assigned to military medical treatment facilities, providing patient care and clinical education including those at the three military infectious diseases training programs (National Capital Consortium, Bethesda MD; Naval Medical Center, San Diego CA; San Antonio Uniformed Services Health Education Consortium, San Antonio TX). Additionally, some ID faculty are assigned to the United States and overseas military research laboratories. Among USU-billeted Medicine ID faculty there are a range of research interests, including viruses (e.g. HIV, SARs-COV2), antimicrobial resistance, vaccines, and parasites as well as technical approaches of structural biology, immunology, and clinical trials. Besides research, our ID faculty contribute to clinical education supporting USU medical student training, graduate programs, as well as training of post graduate physicians during residency and ID fellowship.  All billeted ID physicians provide clinical care in military healthcare system, both outpatient and inpatient services in the National Capital Region.

Our Vision 

Inspire academic excellence in ID across the Military Health System through collaboration, innovative discovery and scholarship, skilled clinical care, inclusive education, and mentorship that will translate to improved health care for those who defend us.

Our Mission

Execute School of Medicine/ Medicine Department mission to foster excellence in militarily relevant training, education and scholarship/discovery.

Billeted Staff

Naomi Aronson M.D., MACP, FIDSA: Director, USU

Mr. Froilan Orille: Program Administrative Specialist, USU

Marzena Pazgier MS, PhD

Catherine Decker MD, FACP, FIDSA

Deputy Director

COL Paul Robben, M.D., Ph.D., FACP: Deputy Director, Walter Reed Army Institute of Research

Our Labs: 

Infectious Disease- Aronson Lab 

Infectious Disease- Pazgier Lab 

Recent News: 

Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120

Structure-function analyses reveal key molecular determinants of HIV-1 CRF01_AE resistance to the entry inhibitor temsavir